ATE25238T1 - Pharmazeutische zusammensetzungen zur behandlung von entzuendungen oder arthritis. - Google Patents
Pharmazeutische zusammensetzungen zur behandlung von entzuendungen oder arthritis.Info
- Publication number
- ATE25238T1 ATE25238T1 AT83307304T AT83307304T ATE25238T1 AT E25238 T1 ATE25238 T1 AT E25238T1 AT 83307304 T AT83307304 T AT 83307304T AT 83307304 T AT83307304 T AT 83307304T AT E25238 T1 ATE25238 T1 AT E25238T1
- Authority
- AT
- Austria
- Prior art keywords
- metal
- monocopper
- complex
- arthritis
- inflammation
- Prior art date
Links
- 206010061218 Inflammation Diseases 0.000 title 1
- 206010003246 arthritis Diseases 0.000 title 1
- 230000004054 inflammatory process Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- QDUNDCWSEGVAAB-UHFFFAOYSA-L copper;2-(carboxymethyl)-2-hydroxybutanedioate Chemical class [Cu+2].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O QDUNDCWSEGVAAB-UHFFFAOYSA-L 0.000 abstract 2
- 238000010494 dissociation reaction Methods 0.000 abstract 2
- 230000005593 dissociations Effects 0.000 abstract 2
- 229910052751 metal Inorganic materials 0.000 abstract 2
- 239000002184 metal Substances 0.000 abstract 2
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 229940124346 antiarthritic agent Drugs 0.000 abstract 1
- 239000003435 antirheumatic agent Substances 0.000 abstract 1
- 150000004696 coordination complex Chemical class 0.000 abstract 1
- XLRBGXUPVNNEND-UHFFFAOYSA-K copper;dilithium;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Li+].[Li+].[Cu+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O XLRBGXUPVNNEND-UHFFFAOYSA-K 0.000 abstract 1
- 238000010586 diagram Methods 0.000 abstract 1
- UZLGHNUASUZUOR-UHFFFAOYSA-L dipotassium;3-carboxy-3-hydroxypentanedioate Chemical compound [K+].[K+].OC(=O)CC(O)(C([O-])=O)CC([O-])=O UZLGHNUASUZUOR-UHFFFAOYSA-L 0.000 abstract 1
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 abstract 1
- 229910001385 heavy metal Inorganic materials 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 239000013110 organic ligand Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/315—Zinc compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/30—Copper compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/265—Citric acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Rheumatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44742482A | 1982-12-06 | 1982-12-06 | |
| EP83307304A EP0115130B1 (de) | 1982-12-06 | 1983-11-30 | Pharmazeutische Zusammensetzungen zur Behandlung von Entzündungen oder Arthritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE25238T1 true ATE25238T1 (de) | 1987-02-15 |
Family
ID=23776326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT83307304T ATE25238T1 (de) | 1982-12-06 | 1983-11-30 | Pharmazeutische zusammensetzungen zur behandlung von entzuendungen oder arthritis. |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0115130B1 (de) |
| JP (1) | JPH0647535B2 (de) |
| AT (1) | ATE25238T1 (de) |
| CA (1) | CA1218600A (de) |
| DE (1) | DE3369506D1 (de) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5106841A (en) * | 1986-05-13 | 1992-04-21 | Chai-Tech Corporation | Antiviral compositions and method for their use |
| US5258403A (en) * | 1986-05-13 | 1993-11-02 | Chai-Tech Corporation | Metallo-organic salt compounds and pharmaceutical uses thereof |
| US5049557A (en) * | 1986-05-13 | 1991-09-17 | Chai-Tech Corporation | Metallo-organic salt compounds and pharmaceutical uses thereof |
| IL82376A (en) * | 1986-05-13 | 1991-06-10 | Chai Tech Corp | Pharmaceutical composition for the treatment of inflammatory conditions |
| US4782048A (en) * | 1986-09-09 | 1988-11-01 | Nelson Research & Development Co. | Method for treating or preventing bovine mastitis |
| EP1128824A1 (de) | 1998-11-09 | 2001-09-05 | Ira Jay Newman | Ionischer silberkomplex |
| EP1811846A4 (de) * | 2004-10-25 | 2009-07-22 | Nat Res Lab Ltd | Verfahren zur herstellung und verwendung synergistischer multifunktioneller zusammensetzungen |
| CA2585340A1 (en) * | 2004-10-25 | 2006-05-04 | National Research Laboratories, Ltd. | Compositions and methods of dispensing palliative or therapeutic agents |
| US8247072B2 (en) | 2006-02-14 | 2012-08-21 | Eastman Chemical Company | Resol beads, methods of making them and methods of using them |
| US10398733B2 (en) | 2013-03-15 | 2019-09-03 | Cda Research Group, Inc. | Topical copper ion treatments and methods of treatment using topical copper ion treatments in the dermatological areas of the body |
| US11007143B2 (en) | 2013-03-15 | 2021-05-18 | Cda Research Group, Inc. | Topical copper ion treatments and methods of treatment using topical copper ion treatments in the oral-respiratory-otic areas of the body |
| US11083750B2 (en) | 2013-03-15 | 2021-08-10 | Cda Research Group, Inc. | Methods of treatment using topical copper ion formulations |
| US12318406B2 (en) | 2013-03-15 | 2025-06-03 | Cda Research Group, Inc. | Methods of treatment using topical copper ion formulations |
| US11318089B2 (en) | 2013-03-15 | 2022-05-03 | Cda Research Group, Inc. | Topical copper ion treatments and methods of making topical copper ion treatments for use in various anatomical areas of the body |
| US11000545B2 (en) | 2013-03-15 | 2021-05-11 | Cda Research Group, Inc. | Copper ion compositions and methods of treatment for conditions caused by coronavirus and influenza |
| AU2017326244B2 (en) * | 2016-09-14 | 2023-07-06 | Cda Research Group, Inc. | Methods of treatment using topical copper ion formulations |
| US11193184B2 (en) | 2019-02-22 | 2021-12-07 | Cda Research Group, Inc. | System for use in producing a metal ion suspension and process of using same |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB827521A (en) * | 1957-03-27 | 1960-02-03 | Director Of Technical Services | New organic copper compounds and solutions and mixtures containing the same, and processes for the preparation of such compounds |
| FR2399847A1 (fr) * | 1977-08-11 | 1979-03-09 | Nat Res Lab | Agents antimicrobiens et leur application |
| JPS5437824A (en) * | 1977-08-30 | 1979-03-20 | Nat Risaachi Lab | Bacteriocide comprising metal complex compound |
| JPS5490121A (en) * | 1977-11-28 | 1979-07-17 | Boettcher Barry | Neutral copper bonded body and antiinflaming agent |
| EP0046409A1 (de) * | 1980-08-20 | 1982-02-24 | Erwin Günther Walliczek | Verfahren zur Herstellung einer Lösung eines Kupfer(I)komplexes, Lösungen der Kupfer(I)komplexe zur Verwendung in der therapeutischen Behandlung des menschlichen oder tierischen Körpers und Methode zur therapeutischen Behandlung einer Pflanze |
-
1983
- 1983-11-08 CA CA000440749A patent/CA1218600A/en not_active Expired
- 1983-11-30 AT AT83307304T patent/ATE25238T1/de not_active IP Right Cessation
- 1983-11-30 EP EP83307304A patent/EP0115130B1/de not_active Expired
- 1983-11-30 DE DE8383307304T patent/DE3369506D1/de not_active Expired
- 1983-12-05 JP JP58229737A patent/JPH0647535B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0115130B1 (de) | 1987-01-28 |
| JPH0647535B2 (ja) | 1994-06-22 |
| CA1218600A (en) | 1987-03-03 |
| EP0115130A1 (de) | 1984-08-08 |
| DE3369506D1 (en) | 1987-03-05 |
| JPS59112915A (ja) | 1984-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE25238T1 (de) | Pharmazeutische zusammensetzungen zur behandlung von entzuendungen oder arthritis. | |
| ATE105482T1 (de) | Behandlung von krebs mit somatostatin und mit analogen davon. | |
| DE3482041D1 (de) | Verbindungen mit entzuendungshemmender aktivitaet, hergestellt durch komplexierung mit beta-cyclodextrin und pharmazeutische zusammensetzungen welche diese enthalten. | |
| DE69005394D1 (de) | Zusammensetzungen welche komplexe von hyaluronsäure enthalten und verfahren zu deren herstellung. | |
| DE69431476D1 (de) | Einschlusskomplexe von taxol oder taxotere oder taxus-extrakten und cyclodextrinen, ihre herstellung und ihre verwendung | |
| DE3873428D1 (de) | Antiinflammatorisch wirkende furanone. | |
| PT88275A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo 5-amino ou amino substituido-1,2,3-triazois uteis como agentes antiproliferativos | |
| EP0307786A3 (de) | Deutero-Cholecalciferolderivate, ihre Herstellung und pharmazeutische Anwendung | |
| ATE196083T1 (de) | Verwendung von ferrioxamin-b zur behandlung septischen schocks | |
| DE68920896D1 (de) | N2-(1-Carboxy-3-phenylpropyl)-L-lysinderivate und Verfahren für die Herstellung von Lysinopril mit Hilfe dieser Verbindung. | |
| DE3577709D1 (de) | Platin-intercalativ-komplexe zur behandlung von krebs. | |
| EP0194901A3 (de) | Derivate des Isoprenoidamines, Zusammensetzungen die diese enthalten, ihre Herstellung und Verwendung | |
| ATA574379A (de) | Neue n-phenylindolinderivate, ihre herstellung undpharmazeutische praeparate, welche diese verbindungen enthalten | |
| DE3578135D1 (de) | Behandlung eines ultrafiltrats durch elektrodialyse. | |
| DE69433923D1 (de) | Salbe enthaltend mometason-furoat und salicylsäure zur topischen behandlung von psoriasis | |
| ATE149840T1 (de) | Behandlung von leberkrebs | |
| ES2084680T3 (es) | Procedimiento de conversion quimica de substratos metalicos, baño utilizado en este procedimiento y concentrado para la preparacion del baño. | |
| RU93003584A (ru) | Способ лечения синдрома поликистозных яичников | |
| ATE36957T1 (de) | N,n-diethyl-5-methyl-2h,1-benzothiopyrano-(4,3, - cd)-indazol-2-ethanamine, diese enthaltende zubereitungen und ihre verwendung. | |
| IT8220583A0 (it) | Complessi organometallici di n-cicloesil-piperazino-acetammidi o propionammidi, loro preparazione e impiego come farmaci antiulcera-antisecretivi-tamponanti . | |
| PT76582B (de) | 1,2,4-triazol-1-yl-propionitrile verfahren zur herstellung dieser verbindungen sowie diese enthaltende biozide mittel | |
| DE3774373D1 (de) | Komplexe von platin-(ii) von 2,3 dinitrilo-2-buten-2,3-dithiolat, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen, die sie enthalten. | |
| BE827197A (fr) | Complexes d'halogenures metalliques et de 4-cyand-2,2-dimethylbutyraldoxime-n-methylcarbamate utilises comme pesticides | |
| JPS5238018A (en) | Fungicides for agriculture and gardening use | |
| FR2313323A1 (fr) | Installation d'epuration biologique d'eaux residuaires |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |